Naked mole-rat

The naked mole-rat (Heterocephalus glaber) is a small subterranean rodent of the Horn of Africa that serves as comparative biogerontology's central example of negligible senescence — a mammal whose measured risk of dying does not climb with age. It lives roughly ten times longer than a mouse of similar size, resists spontaneous tumours, and survives oxygen deprivation that kills other mammals within minutes. Each of those traits has a proposed mechanism and a body of laboratory work behind it. None has yet produced an intervention tested in people.

§The animal

Naked mole-rats live in sealed burrow systems in the arid soils of Somalia, Ethiopia and Kenya, in colonies of tens to a few hundred animals. They are eusocial: a single female breeds, and the rest of the colony is reproductively suppressed and divided into castes that dig, forage and defend. Jennifer Jarvis described the arrangement in 1981, the first time eusociality had been documented in a mammal.¹ They are hairless, effectively blind, and poikilothermic — body temperature tracks the burrow rather than being defended against it.

The relevant number is the mismatch between size and lifespan. A 35-gram rodent should live a few years; captive naked mole-rats have exceeded thirty, several times longer than allometry predicts for their mass and far beyond any other rodent. That gap is what drew biogerontology to the species, and it is the reason the animal appears in nearly every discussion of what sets species-specific lifespan.

1. 1981
   Eusociality described
   Jennifer Jarvis reports in Science that a single female breeds in each colony, with the rest divided into non-reproductive castes.
2. 2011
   Genome published
   Kim et al. sequence the genome and report features consistent with tumour resistance, hairlessness and tolerance of low oxygen.
3. 2013
   Hyaluronan mechanism
   Tian et al. show that naked mole-rat cells secrete an unusually high-molecular-mass hyaluronan, and that removing it makes them susceptible to experimental transformation.
4. 2016
   First cancers reported
   Delaney et al. describe two tumours in zoo-housed animals, qualifying the claim that the species is cancer-proof.
5. 2017
   Fructose switch
   Park et al. report that the animals survive 18 minutes of total anoxia by running glycolysis on fructose.
6. 2018
   Flat mortality curve
   Ruby, Smith and Buffenstein analyse 3,329 colony records and find no detectable rise in hazard with age.
7. 2022
   Somatic mutation rate
   Cagan et al. place the species near the slow end of a cross-species scaling between mutation rate and lifespan.
8. 2023
   Transferred to mice
   Zhang et al. report that mice carrying the naked mole-rat hyaluronan synthase gene develop fewer tumours and live modestly longer.

Rochelle Buffenstein assembled and maintained the colonies most of this work rests on, first in academic laboratories and later at Calico Life Sciences, which recruited her and the animals in the 2010s. The other major line runs through Vera Gorbunova and Andrei Seluanov's laboratory at Rochester, which supplied the cell-biology side. Nearly all published naked mole-rat demography traces back to a small number of captive colonies, which is both why the records are so complete and why they are contested.

§The mortality curve

In almost every mammal studied, the chance of dying in the next interval rises roughly exponentially with age after maturity — the Gompertz pattern, which in humans amounts to a doubling every seven or eight years. Ruby, Smith and Buffenstein compiled 3,329 naked mole-rat records with resolved birth and death dates and found no such rise: the daily hazard stayed below one in ten thousand across the whole observed range, with no detectable increase after sexual maturity at about six months.²

What the claim is

The result is about the shape of the mortality curve, not about immortality. Naked mole-rats die — of infection, of injury, occasionally of cancer. What is absent is the acceleration, which is the demographic signature aging normally leaves.

The analysis drew a formal published comment. Dammann and colleagues argued in 2019 that the dataset is skewed toward recent births: about 87% of the animals were observed for eight years or less, roughly a quarter of the documented maximum lifespan, and fewer than one per cent reached eighteen years.³ They also noted a long stretch of the colony history with no recorded deaths, which would depress hazard estimates, and showed with data from a related genus that simulated record loss inflates median survival substantially. The original authors had already conceded that they could not rule out an as-yet-undetectable Gompertzian component. The honest summary is that the curve is flat over the range that has been well observed, and that range does not yet cover old age as the species defines it.

§Cancer resistance

Tumours were not seen in the species at all for decades of colony records, which made it a natural test case for why large or long-lived animals are not overrun by Cancer. Tian and colleagues found that naked mole-rat fibroblasts secrete hyaluronan of unusually high molecular mass, that it triggers early contact inhibition in culture, and that removing it renders the cells susceptible to experimental transformation.⁴ The responsible enzyme, hyaluronan synthase 2, differs from its mouse counterpart, and the animals also degrade the polymer more slowly.

The absolute version of the claim did not survive. Delaney and colleagues reported two tumours in zoo-housed naked mole-rats in 2016, and further neoplasms have since been described in captive colonies.⁵ "Cancer-resistant" is defensible; "cancer-proof" is not, and the shift matters, because a species with zero tumours and a species with rare tumours imply different mechanisms.

§Hypoxia and metabolism

Sealed burrows crowded with animals run low on oxygen. Park and colleagues reported that naked mole-rats tolerate hours of severe hypoxia and survive eighteen minutes of total anoxia without apparent injury, by switching glycolysis from glucose to fructose — a route that bypasses the phosphofructokinase step where glycolysis normally shuts itself down.⁶ The animals express the fructose transporter GLUT5 broadly and accumulate fructose in the brain under anoxia. The finding is cited as a possible template for limiting damage in stroke and cardiac arrest, and it connects to work on induced metabolic suppression, but no human application has been demonstrated.

§Mechanisms proposed

No single explanation accounts for the species' longevity, and the candidate list overlaps imperfectly with the Hallmarks of aging. Cagan and colleagues sequenced intestinal crypts from sixteen mammals and found somatic mutation rate per year scaling inversely with lifespan; the naked mole-rat accumulates about 93 single-base substitutions a year, close to the giraffe's rate and roughly one-eighth of the mouse's.⁷ Naked mole-rat tissue also maintains higher proteasome activity and more accurate translation than mouse tissue. Against these, the animals carry substantial oxidative damage, tolerate mitochondrial insults that would be expected to shorten life, and show the same senescent-cell accumulation and telomere biology only partly resembling the mouse's. The genome, published in 2011, was read for candidate adaptations rather than delivering a single one.⁸

What the species does not settle

A flat mortality curve is not the same as an absent aging process. Naked mole-rats do show age-related changes in tissue and gene expression; what has not been demonstrated is that those changes translate into rising mortality, systemic inflammation on the mammalian schedule, or the stem cell decline seen in mice.

§What transfers to humans

Nothing, so far. The one result that crossed a species boundary is Zhang and colleagues' transgenic mouse carrying the naked mole-rat hyaluronan synthase gene: tumour incidence in animals over 27 months fell from 83% to 49%, median lifespan rose about 4% and maximum about 12%, with the transcriptional signature shifting toward reduced inflammation.⁹ That is a real effect and a small one, and it is mouse-to-mouse.

A title worth reading closely

The preprint of the 2023 study was called "Increased hyaluronan by naked mole-rat HAS2 extends lifespan in mice". The version published in Nature is called "improves healthspan in mice". The lifespan numbers are in both; the framing changed in review, which is a fair signal of how much weight a 4% median gain in one mouse strain will carry.

Moving further would mean a Gene therapy for aging problem: delivering or editing a synthase gene in human tissue, with the difficulties that somatic delivery always brings. The alternative is a small molecule that raises high-mass hyaluronan without the risks that come with a matrix polymer implicated in tissue remodelling, and no such compound has been described. Hyaluronic acid is already used in medicine, in dermal fillers and joint injections, at molecular masses far below the naked mole-rat's and with no claim on aging. The species' broader contribution is evidential rather than pharmacological: it is the strongest existing argument that mammalian mortality acceleration is not obligatory, which is the premise the Geroscience hypothesis rests on.

§Limits of the model

Captivity confounds the demography. Colony animals receive veterinary care and face none of the predation, drought or intercolony conflict that shape wild mortality, and wild lifespan data for the species barely exist. Eusociality confounds it further: breeders and non-breeders differ physiologically, and a caste system with reproductive suppression has no human analogue, so the comparison that matters, between this rodent and other rodents, has a social variable tangled into it. And the animal is separated from humans by tens of millions of years of evolution, which is why nothing here reads as directly as a mouse result does, for better and worse.

The deeper limit is the one every comparative programme hits. Long-lived species each solved the problem differently, so there is no shared mechanism to copy, and a trait that evolved inside one genome does not necessarily do anything useful inside another. Borrowing a gene from an extreme organism is a strategy with a poor record — the same difficulty applies to tardigrade damage-suppression genes.

§Outlook

Work continues on all three fronts: the demography as the founding cohorts age into the range Dammann's critique says is undersampled, the hyaluronan pathway as a druggable target, and the anoxia response as a route to ischaemia protection. Proponents of comparative biogerontology argue that a mammal with a flat hazard curve proves the ceiling on human lifespan is biological rather than thermodynamic, and that finding the mechanism is therefore worth a decade of basic work. The counterargument is that a decade of it has already produced one modest mouse study, and that interventions with human data behind them, such as dietary restriction and exercise, remain the comparator any naked mole-rat-derived candidate would have to beat, as does Rapamycin in the animal literature. Neither position has been settled by evidence, and no biomarker currently in use would detect the difference early enough to adjudicate it in a human trial.

§See also

• Negligible senescence
• Cancer
• Hallmarks of aging
• Maximum human lifespan
• Geroscience hypothesis
• Calico Life Sciences
• Proteostasis collapse
• Healthspan

§References